Insulin-like growth factor-I (IGF-I) and clinical nutrition

Clinical Science

Volumn 125, Issue 6, 2013, Pages 265-280

  Livingstone, Callum ^a,b  

^a ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Clinical nutrition; Free insulin like growth factor I (free IGF I); Insulin like growth factor I (IGF I); Malnutrition; Obesity

Indexed keywords

ESSENTIAL AMINO ACID; INSULIN; SOMATOMEDIN C;

ANOREXIA NERVOSA; ARTICLE; CALORIC RESTRICTION; CELL PROLIFERATION; CHILD NUTRITION; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; GROWTH HORMONE RELEASE; HUMAN; INSULIN SENSITIVITY; INTRACELLULAR SIGNALING; KWASHIORKOR; MALNUTRITION; METABOLIC SYNDROME X; NUTRITION; NUTRITIONAL ASSESSMENT; NUTRITIONAL REQUIREMENT; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REFEEDING SYNDROME; SCREENING TEST; SHORT BOWEL SYNDROME;

ANIMALS; BIOLOGICAL MARKERS; GENE EXPRESSION REGULATION; HUMANS; INSULIN-LIKE GROWTH FACTOR I; NUTRITION ASSESSMENT; NUTRITION DISORDERS; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; PROGNOSIS;

EID: 84878642470     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20120663     Document Type: Article

References (183)

1. Salmon, W. D. and Daughaday, W. H. (1957) A hormonally controlled serum factor which stimulates sulphate incorporation by cartilage in vitro. J. Lab. Clin. Med. 49, 825-826
2. Daughaday, W. H., Hall, K., Raben, M. S., Salmon, W. D., van den Brande, J. L. and Van Wyk, J. J. (1972) Somatomedin: proposed designation for sulphation factor. Nature 235, 107
3. Lupu, F., Terwilliger, J. D., Lee, K., Segre, J. V. and Efstratiadis, A. (2001) Roles of growth hormone and insulin-like growth factor 1 in mouse post-natal growth. Dev. Biol. 229, 141-162
4. Le Roith, D., Bondy, C., Yakar, S., Liu, J. L. and Butler, A. (2001) The somatomedin hypothesis 2001. Endocr. Rev. 22, 53-74
5. Grant, D. B., Hambley, J., Becker, D. and Pimstone, B. L. (1973) Reduced sulphation factor in undernourished children. Arch. Dis. Child. 48, 596-600
6. Stratton, R. and Elia, M. (2000) How much under nutrition is there in British hospitals?. Brit. J. Nutr. 84, 257-259
7. Delmi, M., Rapin, C. H., Bengoa, J. M., Delmas, P. D., Vasey, H. and Bonjour, J. P. (1990) Dietary supplementation in elderly patients with fractured neck of femur. Lancet 335, 1013-1016
8. De Legge, M. H. and Drake, L. M. (2007) Nutritional assessment. Gastroenterol. Clin. North Am. 36, 1-22
9. Elia, M., Zellipour, L. and Stratton, R. J. (2005) To screen or not to screen for adult malnutrition? Clin. Nutr. 24, 867-884
10. Elia, M. (2003) The 'MUST' Report. Nutritional Screening of Adults: a Multidisciplinary Responsibility, BAPEN, Redditch, http://www.bapen.org.uk/
11. Schofield, W. N. (1985) Predicting basal metabolic rate, new standards and review of previous work. Hum. Nutr.: Clin. Nutr. 39 (Suppl. 1), 5-41
12. Tverskaya, R., Rising, R., Brown, D. and Lifschitz, F. (1998) Comparison of several equations and derivation of a new equation for calculating basal metabolic rate in obese children. J. Am. Coll. Nutr. 17, 333-336
13. NICE (2006) Nutritional Support in Adults: Oral Nutrition Support, Enteral Tube Feeding and Parenteral Nutrition (Clinical Guideline 32), NICE, London, http://www.nice.org.uk/
14. Noel, M., Chevenne, D. and Porquet, D. (2001) Utility of insulin-like growth factor-I and its binding protein assays. Curr. Opin. Clin. Nutr. Metab. Care 4, 399-405
15. Juul, A. (2003) Serum levels of insulin-like growth factor-I and its binding proteins in health and disease. Growth Horm. IGF Res. 13, 113-170
16. Pavelic, J., Matijevic, T. and Knezevic, J. (2007) Biological and physiological aspects of action of insulin-like growth factor peptide family. Ind. J. Med. Res. 125, 511-522
17. Denley, A., Cosgrove, L. J., Booker, G. W., Wallace, J. C. and Forbes, B. E. (2005) Molecular interactions of the IGF system. Cytokine Growth Factor Rev. 16, 421-439
18. Espelund, U., Bruun, J. M., Richelsen, B., Flyvbjerg, A. and Frystyk, J. (2005) Pro- and mature IGF-II during diet induced weight loss in obese subjects. Eur. J. Endocrinol. 153, 861-869
19. O'Dell, S. D. and Day, I. N. M. (1998) Molecules in focus: insulin-like growth factor-II (IGF-II). Int. J. Biochem. Cell Biol. 30, 767-771
20. Clemmons, D. R. (1998) Role of insulin-like growth factor binding proteins in controlling IGF actions. Mol. Cell. Endocrinol. 140, 19-24
21. Jones, J. I. and Clemmons, D. R. (1995) Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 16, 3-34
22. Woodhouse, L. J., Mukherjee, A., Shalet, S. M. and Ezzat, S. (2006) The influence of growth hormone status on physical impairments, functional limitations and health-related quality of life in adults. Endocr. Rev. 27, 287-317
23. Renehan, A. G., Toogood, A. A., Ryder, W. D., Jones, J., Potten, C. S., O'Dwyer, S. T. and Shalet, S. M. (2001) Paradoxical elevations in serum IGF-II and IGF binding protein-2 in acromegaly: insights into the regulation of these peptides. Clin. Endocrinol. 55, 469-475
24. Baxter, R. C. (2001) Changes in the IGF-IGFBP axis in critical illness. Best Pract. Res. Clin. Endocrinol. Metab. 15, 421-434
25. Firth, S. M. and Baxter, R. C. (2002) Cellular actions of the insulin-like growth factor binding proteins. Endocr. Rev. 23, 824-854
26. Davies, S. C., Wass, J. A. H., Ross, R. J. M., Cotterill, A. M., Buchanan, C. R., Coulson, V. J. and Holly, J. M. P. (1991) The induction of a specific protease for insulin-like growth factor binding protein-3 in the circulation during severe illness. J. Endocrinol. 130, 469-473
27. Davenport, M. L., Isley, W. L., Pucilowska, J. B., Pemberton, L. B., Lyman, B., Underwood, L. E. and Clemmons, D. R. (1992) Insulin-like growth factor binding protein-3 proteolysis is induced after elective surgery. J. Clin. Endocrinol. Metab. 75, 590-595
28. Muller, H. L., Oh, Y., Gargosky, S. E., Wilson, K. F., Lehrnbecher, T. and Rosenfeld, G. (1994) Insulin-like growth factor binding protein-3 protease activity in the sera of patients with malignant solid tumors or leukaemia. Pediatr. Res. 35, 720-724
29. Langford, K. S., Nicolaides, K. H., Jones, J., Abbas, A., McGregor, A. M. and Miell, J. P. (1995) Serum insulin-like growth factor binding protein-3 (IGFBP-3) levels and IGFBP-3 protease activity in normal, abnormal and multiple human pregnancy. J. Clin. Endocrinol. Metab. 80, 21-27
30. Salahifar, H., Baxter, R. C. and Martin, J. L. (1997) Insulin-like growth factor (IGF) binding protein-3 protease activity secreted by MCF-7 breast cancer cells: inhibition by IGFs does not require IGF-IGFBP interaction. Endocrinology 138, 1683-1690
31. Conover, C. A., Harrington, S. C., Bale, L. K. and Oxvig, C. (2007) Surface association of pregnancy-associated plasma protein A accounts for its co-localisation with activated macrophages. Am. J. Physiol. Heart Circ. Physiol. 292, H994-H1000
32. Conover, C. A. (2010) PAPP-A: a new anti-aging target?. Aging Cell 9, 942-946
33. Conover, C. A., Bale, L. K., Harrington, S. C., Resch, Z. T., Overgaard, M. T. and Oxvig, C. (2006) Cytokine stimulation of pregnancy-associated plasma protein A expression in human coronary artery smooth muscle cells: inhibition by resveratrol. Am. J. Physiol. Cell Physiol. 290, C183-C188
34. LeRoith, D. and Butler, A. A. (1999) Insulin-like growth factors in paediatric health and disease. J. Clin. Endocrinol. Metab. 84, 4355-4361
35. Jacob, R., Barrett, E., Plewe, G., Fagin, K. D. and Sherwin, R. S. (1989) Acute effects of insulin-like growth factor-I on glucose and amino acid metabolism in the awake fasted rat: comparison with insulin. J. Clin. Invest. 83, 1717-1723
36. Jones, J. I. and Clemmons, D. R. (1995) Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 16, 3-34
37. Yu, H. and Rohan, T. (2000) Role of the insulin-like growth factor family in cancer development and progression. J. Natl. Cancer Inst. 92, 1472-1489
38. Fryburg, D. A., Jahn, L. A., Hill, S. A., Oliveras, D. M. and Barrett, E. J. (1995) Insulin and insulin-like growth factor-I enhance human skeletal muscle protein anabolism during hyperaminoacidaemia by different mechanisms. J. Clin. Invest. 96, 1722-1729
39. Clemmons, D. R. (2009) Role of IGF-I in skeletal muscle mass maintenance. Trends Endocrinol. Metab. 20, 349-356
40. Goldspink, G. (2007) Loss of muscle strength during aging studied at the gene level. Rejuvenation Res. 10, 397-405
41. Schertzer, J. D., Ryall, J. G. and Lynch, G. S. (2006) Systemic administration of IGF-I enhances oxidative status and reduces contraction-induced injury in skeletal muscles of mdx dystrophic mice. Am. J. Physiol. Endocrinol. Metab. 291, E499-E505
42. Gomez, J. M. (2008) Growth hormone and insulin-like growth factor-I as an endocrine axis in Alzheimer's disease. Endocr. Metab. Immun. Disord. Drug Targets 8, 143-151
43. Saukkonen, T., Amin, R., Williams, R. M., Fox, C., Yuen, K. C., White, M. A., Umpleby, A. M., Acerini, C. L. and Dunger, D. B. (2004) Dose-dependent effects of recombinant human insulin-like growth factor (IGF)-I/IGF binding protein-3 complex on overnight growth hormone secretion and insulin sensitivity in type 1 diabetes. J. Clin. Endocrinol. Metab. 89, 4634-4641
44. Kelley, K. W., Weigent, D. A. and Kooijman, R. (2007) Protein hormones and immunity. Brain Behav. Immun. 21, 384-392
45. Ohlsson, C., Mohan, S., Sjogren, K., Tivesten, A., Isgaard, J., Isaksson, O., Jansson, J. and Svensson, J. (2009) The role of liver-derived insulin-like growth factor-I. Endocr. Rev. 30, 494-535
46. Yu, H., Mistry, J., Nicar, M. J, Khosravi, M. J., Diamandis, A., van Doorn, J. and Juul, A. (1999) Insulin-like growth factors (IGF-I, free IGF-I, and IGF-II) and insulin-like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6, and ALS) in blood circulation. J. Clin. Lab. Anal. 13, 166-172
47. Raynaud-Simon, A. (2003) Levels of plasma insulin-like growth factor-I (IGF-I), IGF-II, IGF binding proteins, type 1 IGF receptor and growth hormone binding protein in community-dwelling elderly subjects with no malnutrition and no inflammation. J. Nutr. Health Aging 7, 267-273
48. Hong, Y., Pedersen, N. L., Brismar, K., Hall, K. and de Faire, U.(1996) Quantitative genetic analyses of insulin-like growth factor-I (IGF-I), IGF-binding protein-1 and insulin levels in middle-aged and elderly twins;J. Clin. Endocrinol. Metab., 81, 1791-1797
49. Harrela, M., Koistinen, H., Kaprio, J., Lehtovirta, M., Tuomilehto, J., Eriksson, J., Toivanen, L., Koskenvuo, M., Leinonen, P., Koistinen, R. and Seppala, M. (1996) Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1 and IGFBP-3. J. Clin. Invest. 98, 2612-1615
50. Miell, J. P., Taylor, A. M., Zini, M., Maheshwari, H. G., Ross, R. J. and Valcavi, R. (1993) Effects of hypothyroidism on insulin-like growth factors (IGFs) and growth hormone- and IGF-binding proteins. J. Clin. Endocrinol. Metab. 76, 950-955
51. Chapman, I. M., Hartman, M. L., Pieper, K. S., Skiles, E. H., Pezzoli, S. S., Hintz, R. L. and Thorner, M. O. (1998) Recovery of growth hormone release from suppression by exogenous insulin-like growth factor-I (IGF-I): evidence for a suppressive action of free rather than bound IGF-I. J. Clin. Endocrinol. Metab. 83, 2836-2842
52. Chen, J. W., Hojlund, K., Beck-Nielsen, H., Sandahl, C. J., Orskov, H. and Frystyk, J. (2005) Free rather than total circulating insulin-like growth factor-I determines feedback on growth hormone release in normal subjects. J. Clin. Endocrinol. Metab. 90, 366-371
53. O'Connor, J. C., McCusker, R. H., Strle, K., Johnson, R. W., Dantzer, R. and Kelley, K. W. (2008) Regulation of IGF-I function by proinflammatory cytokines: at the interface of immunology and endocrinology. Cell. Immunol. 252, 91-110
54. Hanaire-Broutin, H., Sallerin-Caute, B., Poncet, M. F., Tauber, M., Bastide, R., Chale, J. J., Rosenfeld, R. and Tauber, J. P. (1996) Effect of intraperitoneal insulin delivery on growth hormone binding protein, insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in IDDM. Diabetologia 39, 1498-1504
55. Boni Schnetzeler, M., Schmid, C., Meier, P. J. and Froesch, E. R. (1991) Insulin regulates insulin-like growth factor-I mRNA in rat hepatocytes. Am. J. Physiol. 260, E846-E851
56. Leung, K. C., Doyle, N., Ballesteros, M., Waters, M. J. and Ho, K. K. (2000) Insulin regulation of human hepatic growth hormone receptors: divergent effects on biosynthesis and surface translocation. J. Clin. Endocrinol. Metab. 85, 4712-4720
57. Frystyk, J. (2004) Free insulin-like growth factors: measurements and relationships to growth hormone secretion and glucose homeostasis. Growth Horm. IGF Res. 14, 337-375
58. Arafat, A. M., Weickert, M. O., Frystyk, J., Spranger, J., Schofl, C., Mohlig, M. and Pfeiffer, A. F. (2009) The role of insulin-like growth factor binding protein-2 in the insulin-mediated decrease in IGF-I bioactivity. J. Clin. Endocrinol. Metab. 94, 5093-6101
59. Clemmons, D. R., Klibanski, A., Underwood, L. E., McArthur, J. W., Ridgway, E. C., Beitins, I. Z. and Van Wyk, J. J. (1981) Reduction of plasma immunoreactive somatomedin C during fasting in humans. J. Clin. Endocrinol. Metab. 53, 1247-1250
60. Smith, S. R., Edgar, P. J., Pozefsky, T., Chhetri, M. K. and Prout, T. E. (1974) Growth hormone in adults with protein-calorie malnutrition. Endocrinology 39, 53-62
61. Hartman, M. L., Clayton, P. E., Johnson, M. L., Celniker, A., Perlman, A. J., Alberti, K. G. and Thorner, M. O. (1993) A low dose euglycaemic infusion of recombinant insulin-like growth factor-I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans. J. Clin. Invest. 91, 2453-2462
62. Nindl, B. C., Rarick, K. R., Castelanni, J. W., Tuckow, A. P., Patton, J. F., Young, A. J. and Montain, S. J. (2006) Altered secretion of growth hormone and luteinizing hormone after 84h of sustained physical exertion superimposed on caloric and sleep restriction. J. Appl. Physiol. 100, 122-128
63. Kirschner, B. S. and Sutton, M. M. (1986) Somatomedin C levels in growth impaired children and adolescents with chronic inflammatory bowel disease. Gastroenterology 91, 830-836
64. Thissen, J. P., Ketelslegers, J. M. and Underwood, L. E. (1994) Nutritional regulation of the insulin-like growth factors. Endocr. Rev. 15, 80-101
65. Fazeli, P., Lawson, E., Prabhakaran, R., Miller, K. K., Donoho, D., Clemmons, D. R., Herzog, D. B., Misra, M. and Klibanski, A. (2010) Effects of recombinant human growth hormone in anorexia nervosa: a randomised placebo controlled study. J. Clin. Endocrinol. Metab. 95, 4889-4897
66. Donahue, S. P. and Philips, L. S. (1989) Response of IGF-I to nutritional support in malnourished hospital patients: a possible indicator of short term changes in nutritional status. Am. J. Clin. Nutr. 50, 962-969
67. Isley, W. L, Underwood, L. E. and Clemmons, D. R. (1984) Changes in plasma somatomedin C in response to ingestion of diets with variable protein and energy content. JPEN, J. Parenter. Enteral Nutr. 8, 407-411
68. Fontana, L., Weiss, E. P., Villareal, D. T., Klein, S. and Holloszy, J. O. (2008) Long term effects of calorie or protein restriction on serum IGF-I and IGFBP-3 concentrations in humans. Aging Cell 7, 681-687
69. Clemmons, D. R., Seek, M. M. and Underwood, L. E. (1985) Supplemental essential amino acids augment the somatomedin-C/insulin-like growth factor-I response to refeeding after fasting. Metabolism 34, 391-395
70. Abribat, T., Nedelec, B., Jobin, N. and Garrel, D. R. (2000) Decreased serum insulin-like growth factor-I in burn patients: relationship with serum insulin-like growth factor binding protein-3 proteolysis and the influence of lipid composition in nutritional support. Crit. Care Med. 28, 2366-2372
71. Plank, L. D., Connolly, A. B. and Hill, G. L. (1998) Sequential changes in the metabolic response in severely septic patients during the first 23 days after the onset of peritonitis. Ann. Surg. 228, 146-158
72. Fleck, A. (1989) Clinical and nutritional aspects of changes in acute-phase proteins during inflammation. Proc. Nutr. Soc. 48, 347-354
73. Raynaud-Simon, A., Perin, L., Meaume, S., Lesourd, B., Moulias, R., Postel-Vinay, M. C. and Le Bouc, Y. (2002) IGF-I-binding proteins and GH-binding protein in malnourished elderly patients with inflammation receiving refeeding therapy. Eur. J. Endocrinol. 146, 657-665
74. Spies, M., Wolf, S. E., Barrow, R. E., Jeschke, M. G. and Herndon, D. N. (2002) Modulation of types I and II acute phase reactants with insulin-like growth factor-I/binding protein-3 complexes in severely burned children. Crit. Care Med. 30, 83-88
75. Nedelec, B., de Oliveira, A. and Garrel, D. R. (2003) Acute phase modulation of systemic insulin-like growth factor-I and its binding proteins after major burn injuries. Crit. Care Med. 31, 1794-1801
76. Garcia-de-Lorenzo, A., Ortiz-Leyba, C., Planas, M., Montejo, J. C., Nunez, R., Ordonez, F. J., Aragon, C. and Jimenez, F. J. (1997) Parenteral administration of different amounts of branch-chain amino acids in septic patients: clinical and metabolic aspects. Crit. Care Med. 25, 418-424
77. Cooney, R. N. and Shumate, M. (2006) The inhibitory effects of interleukin-1 on growth hormone action during catabolic illness. Vitam. Horm. 74, 317-340
78. Skjaerbaek, C., Frystyk, J., Orskov, H., Kissmeyer-Nielsen, P., Jensen, M. B., Laurberg, S., Moller, N. and Flyvbjerg, A. (1998) Differential changes in free and total insulin-like growth factor-I after major, elective abdominal surgery: the possible role of insulin-like growth factor binding protein-3 proteolysis. J. Clin. Endocrinol. Metab. 83, 2445-2449
79. Ye, M., Yu, H., Yu, W., Zhang, G., Xiao, L., Zheng, X. and Wu, J. (2012) Evaluation of the significance of circulating insulin-like growth factor-I and C-reactive protein in patients with chronic obstructive pulmonary disease. J. Int. Med. Res. 40, 1025-1035
80. Broussard, S. R., McCusker, R. H., Novakofski, J. E., Strle, K., Shen, W. H., Johnson, R. W., Freund, G. G., Dantzer, R. and Kelley, K. W. (2003) Cytokine-hormone interactions: tumor necrosis factor a impairs biologic activity and downstream activation signals of the insulin-like growth factor-I receptor in myoblasts. Endocrinology 144, 2988-2996
81. Frost, R. A., Lang, C. H. and Gelato, M. C. (1997) Transient exposure of human myoblasts to tumor necrosis factor-a inhibits serum and insulin-like growth factor-I stimulated protein synthesis. Endocrinology 138, 4153-4159
82. Thissen, J. P., Underwood, L. E. and Ketelslegers, J. M. (1999) Regulation of insulin-like growth factor-I in starvation and injury. Nutr. Rev. 57, 167-176
83. Sharshar, T., Bastuji-Garin, S, Polito, A., de Jonghe, B., Stevens, R. D, Maxime, V., Rodriguez, P., Cerf, C., Outin, H., Touraine, P. and Laborde, K. (2011) Hormonal status in protracted critical illness and in hospital mortality. Crit. Care 15, R47
84. Spate, U. and Schulze, P. C. (2004) Proinflammatory cytokines and skeletal muscle. Curr. Opin. Clin. Nutr. Metab. Care 7, 265-269
85. Dantzer, R. and Kelley, K. W. (2007) Twenty years of research on cytokine-induced sickness behaviour. Brain Behav. Immun. 21, 153-160
86. Takala, J., Ruokonen, E., Webster, N. R., Nielsen, M. S., Zandstra, D. F., Vundelinckx, G. and Hinds, C. J. (1999) Increased mortality associated with growth hormone treatment in critically ill adults. N. Engl. J. Med. 341, 785-792
87. Duska, F., Fric, M., Pazout, J., Waldauf, P., Tuma, P. and Pachl, J. (2008) Frequent intravenous pulses of growth hormone together with alanylglutamine supplementation in prolonged critical illness after multiple trauma: effects on glucose control, plasma IGF-I and glutamine. Growth Horm. IGF Res. 18, 82-87
88. Taylor, B. E. and Buchman, T. G. (2008) Is there a role for growth hormone therapy in refractory critical illness? Curr. Opin. Crit. Care 14, 438-444
89. Xiang, L. and Guoqing, H. (2011) Caloric restriction and antiaging effects. Ann. Nutr. Metab. 58, 42-48
90. Bohannon, R. W. (1997) Comfortable and maximum walking speed of adults aged 20-79 years: reference values and determinants. Age Ageing 26, 15-19
91. Perrini, S., Laviola, L., Carreira, M. C., Cignarelli, A., Natalicchio, A. and Giorgino, F. (2010) The GH/IGF-I axis and signalling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis. J. Endocrinol. 205, 201-210
92. Maggio, M., Dall'Aglio, E., Lauretani, F., Cattabiani, C., Ceresini, G., Caffarra, P., Valenti, G., Volpi, R., Vignali, A., Schiavi, G. and Ceda, J. P. (2012) The hormonal pathway to cognitive impairment in older men. J. Nutr. Health Aging 16, 40-54
93. Brugts, M. P., van den Beld, A. W., Hofland, L. J., van der Wansem, K., van Koetsveld, P. M., Frystyk, J., Lamberts, S. W. and Janssen, J. A. (2008) Low circulating insulin-like growth factor-I bioactivity in elderly men is associated with increased mortality. J. Clin. Endocrinol. Metab. 93, 2515-2522
94. Fair, A. M. and Montgomery, K. (2009) Energy balance, physical activity and cancer risk. Methods Mol. Biol. 472, 57-88
95. LeRoith, D. and Helman, L. (2004) The new kid on the block(ade) of the IGF-I receptor. Cancer Cell 5, 201-202
96. Brabant, G. and Wallaschofski, H. (2007) Normal levels of serum IGF-I: determinants and validity of current reference ranges. Pituitary 10, 129-133
97. Nakago, S., Ueda, Y., Takeuchi, K. and Maruo, T. (2002) Implication of maternal nitrogen balance in the regulation of circulating levels of insulin-like growth factor-I in human pregnancy. Endocr. J. 49, 299-305
98. Caregaro, L., Favaro, A., Santonastaso, P., Alberino, F., Dipascoli, L., Nardi, M., Favaro, S. and Gatta, A. (2001) Insulin-like growth factor-I (IGF-I), a nutritional marker in patients with eating disorders. Clin. Nutr. 20, 2511-2517
99. Swenne, I., Stridsberg, M., Thurfjell, B. and Rosling, A. (2007) Insulin-like growth factor-I as an indicator of nutrition during treatment of adolescent girls with eating disorders. Acta Paediatr. 96, 1203-1208
100. Lukanova, A., Lundin, E., Zeleniuch-Jacquotte, A., Muti, P., Mure, A., Rinaldi, S., Dossus, L., Michelli, A., Arslan, A., Lenner, P. et al. (2004) Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross sectional study in healthy women. Eur. J. Endocrinol. 150, 161-171
101. Kim, E. S., Park, J. H., Lee, M. K., Lee, D. H., Kang, E. S, Lee, H. C., Jekal, Y. and Jeon, J. H. (2011) Associations between fatness, IGF and IMT among obese Korean male adolescents. Diabetes Metab. J. 35, 610-618
102. Doyle, S. L, Donohue, C. L, Finn, S. P., Howard, J. M., Lithander, F. E., Reynolds, J. V., Pidgeon, G. P. and Lysaght, J. (2012) IGF-I and its receptor in esophageal cancer: association with adenocarcinoma and visceral adiposity. Am. J. Gastroenterol. 107, 196-204
103. Rasmussen, M. H. (2010) Obesity, growth hormone and weight loss. Mol. Cell. Endocrinol. 316, 147-153
104. Lanfranco, F., Motta, G., Minetto, M. A., Ghigo, E. and Maccario, M. (2010) Growth hormone/insulin-like growth factor-I axis in obstructive sleep apnoea: an update. J. Endocrinol. Invest. 33, 192-196
105. Onder, G., Liperoti, R., Russo, A., Soldato, M., Capoluongo, E., Volpato, S., Cesari, M., Ameglio, F., Bernabei, R. and Landi, F. (2006) Body mass index, free insulin-like growth factor-I and physical function among older adult: results from the ilSIRENTE study. Am. J. Physiol. Endocrinol. Metab. 291, E829-E834
106. Frystyk, J., Skjaerbaek, C., Vestbo, E., Fisker, S. and Orskov, H. (1999) Circulating levels of free insulin-like growth factors in obese subjects: the impact of type-2 diabetes. Diabetes Metab. Res. Rev. 15, 314-322
107. Rasmussen, M. H., Juul, A., Kjems, L. L. and Hilsted, J. (2006) Effects of short term caloric restriction on circulating free IGF-I, acid-labile subunit, IGF-I binding proteins (IGFBPs)-1-4 and IGFBPs-1-3 protease activity in obese subjects. Eur. J. Endocrinol. 155, 575-581
108. Devine, A., Rosen, C., Mohan, S., Baylink, D. and Prince, R. L. (1998) Effects of zinc and other nutritional factors on insulin-like growth factor-I and insulin-like growth factor binding proteins in post-menopausal women. Am. J. Clin. Nutr. 68, 200-206
109. Vinciquerra, M., Musaro, A. and Rosenthal, M. (2010) Regulation of muscle atrophy in aging and disease. Adv. Exp. Med. Biol. 694, 211-233
110. Caufriez, A., Reding, P., Urbain, D., Golstein, J. and Copinschi, G. (19919) Insulin-like growth factor-I: a good indicator of a functional hepatocellular capacity in alcoholic liver cirrhosis. J. Endocrinol. Invest. 14, 317-321
111. Mak, R. H., Cheung, W. W. and Roberts, C. T. (2008) The growth hormone-insulin-like growth factor axis in chronic kidney disease. Growth Horm. IGF Res. 18, 17-25
112. Tonshoff, B., Kiepe, D. and Cirmatori, S. (2005) Growth hormone/insulin-like growth factor system in children with chronic renal failure. Pediatr. Nephrol. 20, 279-289
113. Purandare, A., Co Ng, L., Godil, M., Ahnn, S. H. and Wilson, T. A. (2003) Effect of hypothyroidism and its treatment on the IGF system in infants and children. J. Pediatr. Endocrinol. Metab. 16, 35-42
114. Clemmons, D. R. (2006) Clinical utility of measurements of insulin-like growth factor-I. Nat. Clin. Pract. Endocrinol. Metab. 2, 436-446
115. Gomez, J. M., Maravall, F. J., Gomez, N., Navarro, M. A, Casamitjana, R. and Soler, J. (2004) The IGF-I system component concentrations that decrease with ageing are lower in obesity in relationship to body mass index and body fat. Growth Horm. IGF Res. 14, 91-96
116. Hintz, R. L., Suskind, R., Amatayakul, K., Thanangkul, O. and Olson, R. (1978) Plasma somatomedin and growth hormone values in children with protein calorie malnutrition. J. Pediatr. 92, 153-156
117. Hill, K. K., Hill, D. B., McClain, M. P., Humphries, L. L. and McClain, C. J. (1993) Serum insulin-like growth factor-I concentrations in the recovery of patients with anorexia nervosa. J. Am. Coll. Nutr. 12, 475-478
118. Campillo, B., Paillaud, E., Bories, P. N., Noel, M., Porquet, D. and Le Parco, J. C. (2000) Serum levels of insulin-like growth factor-I in the three months following surgery for a hip fracture in elderly: relationship with nutritional status and inflammatory reaction. Clin. Nutr. 19, 349-354
119. Clemmons, D. R., Underwood, L. E., Dickerson, R. N., Brown, R. O., Hak, W., MacPhee, R. D. and Heizer, W. D. (1985) Use of plasma somatomedin-C/insulin-like growth factor-I measurements to monitor the response to nutritional repletion in malnourished patients. Am. J. Clin. Nutr. 41, 191-198
120. Unterman, T. G., Vazquez, R. M., Sla, A. J., Martyn, P. A. and Phillips, L. S. (1985) Nutrition and somatomedin-C in nutritional assessment. Am. J. Med. 78, 228-234
121. Gianott, L., Lanfranco, F., Ramunni, J., Destefanis, S., Ghigo, E. and Arvat, E. (2002) GH/IGF-I axis in anorexia nervosa. Eat. Weight Disord. 7, 94-105
122. Counts, D. R., Gwirtsman, H., Carlsson, L. M. S., Lesem, M. and Cutler, G. B. (1992) The effect of anorexia nervosa and refeeding on growth hormone-binding protein, the insulin-like growth factors (IGFs), and the IGF-binding proteins. J. Clin. Endocrinol. Metab. 75, 762-767
123. Misra, M. and Klibanski, A. (2011) Bone health in anorexia nervosa. Curr. Opin. Endocrinol., Diabetes Obes. 18, 376-382
124. Winston, A. P. (2012) The clinical biochemistry of anorexia nervosa. Ann. Clin. Biochem. 49, 132-143
125. Lawson, E. A. and Klibanski, A. (2008) Endocrine abnormalities in anorexia nervosa. Nat. Clin. Pract. Endocrinol. Metab. 4, 407-414
126. Soyka, L. A., Grinspoon, S., Levitsky, L. L., Herzog, D. B. and Klibanski, A. (1999) The effects of anorexia nervosa on bone metabolism in female adolescents. J. Clin. Endocrinol. Metab. 84, 4489-4496
127. Soyka, L., Misra, M., Frenchman, A., Miller, K., Grinspoon, S., Schoenfeld, D. and Klibanski, A. (2002) Abnormal bone mineral accrual in adolescent girls with anorexia nervosa. J. Clin. Endocrinol. Metab. 87, 4177-4185
128. Lifshitz, F. (2009) Nutrition and growth. J. Clin. Res. Pediatr. Endocrinol. 1, 157-163
129. Smith, W. J., Underwood, L. E., Keyes, L. and Clemmons, D. R. (1997) Use of insulin-like growth factor-I (IGF-I) and IGF-binding protein measurements to monitor feeding of premature infants. J. Clin. Endocrinol. Metab. 82, 3982-3988
130. Wan Nazaimoon, W. M., Osman, A., Wu, L. L. and Khalid, B. A. (1996) Effects of iodine deficiency on insulin-like growth factor-I, insulin-like growth factor binding protein-3 levels and height attainment in malnourished children. Clin. Endocrinol. 45, 79-83
131. Sermet-Gaudelus, I., Souberbielle, J. C., Azhar, I., Ruiz, J. C., Magnine, P., Colomb, V., Le Bihan, C., Folio, D. and Lenoir, G. (2003) Insulin-like growth factor-I correlates with lean body mass in cystic fibrosis patients. Arch. Dis. Child. 88, 956-961
132. Ozen, M., Cokugras, H., Ozen, N., Camcioglu, Y. and Akcakaya, N. (2004) Relation between serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 levels, clinical status and growth parameters in pre-pubertal cystic fibrosis patients. Pediatr. Int. 46, 429-435
133. Chantry, C. J., Hughes, M. D, Alvero, C., Cervia, J. S., Hodge, J., Borum, P. and Moye, J. (2008) Insulin-like growth factor-I and lean body mass in HIV infected children. J. Acquired Immune Defic. Syndr. 48, 437-443
134. Dinleyici, E. C., Kilic, Z., Buyukkaragoz, B., Ucar, B., Alatas, O., Aydogdu, S. D. and Dogruel, N. (2007) Serum IGF-I, IGFBP-3 and growth hormone levels in children with congenital heart disease: relationship with nutritional status, cyanosis and left ventricular functions. Neuroendocrinol. Lett. 28, 279-283
135. Lifshitz, F., Friedman, S., Smith, M. M., Cervantes, C., Recker, B. and O'Connor, M. (1997) Nutritional dwarfing: a growth abnormality associated with reduced erythrocytes Na+, K+ ATPase activity. J. Am. Coll. Nutr. 16, 159-165
136. Rikke, B. A., Yerg, J. E., Battaglia, M. E., Nagy, T. R., Allison, D. B. and Johnson, T. E. (2003) Strain variation in the response to dietary restriction. Mech. Ageing Dev. 124, 663-678
137. Ketelslegers, J. M., Maiter, D., Maes, M., Underwood, L. E. and Thissen, J. P. (1995) Nutritional regulation of insulin-like growth factor-I. Metab., Clin. Exp. 44, 50-57
138. Marin, V. B., Rebollo, M. G., Castillo-Duran, C. D., Lopez, M. T., Sanabria, M. S., Moraga, F. M., Castro, F. and Barrera, F. Q. (1999) Controlled study of early post-operative parenteral nutrition in children. J. Pediatr. Surg. 34, 1330-1335
139. Barksdale, E. M., Koehler, A. N., Yaworski, J. A., Gardner, M. and Reyes, J. (1999) Insulin-like growth factor-I and insulin-like growth factor binding protein-3: indices of intestinal failure in children. J. Pediatr. Surg. 34, 655-661
140. Nucci, A. M., Reyes, J., Yaworski, J. A., Mazariegos, G., Beserock, N. and Barksdale, E. M. (2003) Serum growth factors and growth indices pre- and post-pediatric intestinal transplantation. J. Pediatr. Surg. 38, 1043-1047
141. Goulet, O., Dabbas-Tyan, M., Taboltec, C., Kapel, N., Rosilio, M., Souberbielle, J. C., Corriol, O., Ricour, C. and Colomb, V. (2010) Effect of recombinant human growth hormone on intestinal absorption and body composition in children with short bowel syndrome. J. Parenter. Enteral Nutr. 34, 513-520
142. Crook, M. A., Hally, V. and Pantelli, J. V. (2001) The importance of the refeeding syndrome. Nutrition 17, 632-637
143. Kagansky, N., Levy, S., Koren-Morag, N., Berger, D. and Knobler, H. (2005) Hypophosphataemia in old patients is associated with the refeeding syndrome and reduced survival. J. Int. Med. 257, 461-468
144. Elnenaei, M. O., Alaghband-Zadeh, J., Sherwood, R., Awara, M. A., Moniz, C. and le Roux, C. W. (2011) Leptin and insulin-like growth factor-I: diagnostic markers of the refeeding syndrome and mortality. Br. J. Nutr. 106, 906-912
145. Fowke, J. H., Matthews, C. E., Yu, H., Cai, Q., Cohen, S., Buchowski, M. S., Zheng, W. and Blot, W. J. (2010) Racial differences in the association between body mass index and serum IGF-I, IGF-II and IGFBP-3. Endocr.-Relat. Cancer 17, 51-60
146. Espelund, U., Bruun, J. M., Richelsen, B., Flyvberg, A. and Frystyk, J. (2005) Pro- and mature IGF-II during diet-induced weight loss in obese subjects. Eur. J. Endocrinol. 153, 861-869
147. Stoving, R. K., Chen, J. W., Glintborg, G., Brixen, K., Flyvbjerg, A., Horder, K. and Frystyk, J. (2007) Bioactive insulin-like growth factor (IGF)-I and IGF binding protein-1 in anorexia nervosa. J. Clin. Endocrinol. Metab. 92, 2323-2329
148. Nindl, B. C., Alemany, J. A., Kellogg, M. D., Rood, J., Allison, S. A., Young, A. J. and Montain, S. J. (2007) Utility of insulin-like growth factor-I as a biomarker for assessing short-term metabolic stress in healthy men. J. Appl. Physiol. 103, 340-346
149. Saitoh, H., Kamoda, T., Nakahara, S., Hirano, T. and Matsui, A. (1999) Insulin-like growth factor binding protein-1 as a predictor of glucose stimulated hyperinsulinaemia in pre-pubertal obese children. Eur. J. Endocrinol. 140, 231-234
150. Heald, A. H., Kaushal, K., Siddals, K. W., Rudenski, A. S., Anderson, S. G. and Gibson, J. M. (2006) Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome. Exp. Clin. Endocrinol. Diabetes 114, 371-376
151. Gram, I. T., Norat, T., Piraldi, S., Dossus, L., Lukanova, A., Tehard, B., Clavel-Chapelon, F., van Gils, C. H., van Noord, P. A., Peeters, P. H. et al. (2006) Body mass index, waist circumference and waist-hip ratio and serum levels of IGF-I and IGFBP-3 in European women. Int. J. Obes. 30, 1623-1631
152. Schneider, H. J., Saller, B., Klotsche, J., Marz, W., Erwa, W., Wittchen, H. U. and Stall, G. K. (2006) Opposite associations of age-dependent insulin-like growth factor-I standard deviation scores with nutritional state in normal weight and obese subjects. Eur. J. Endocrinol. 154, 699-706
153. Kretschmann-Andermahr, I., Suarez, P., Fennings, R., Evers, N. and Brabant, G. (2010) GH/IGF-I regulation in obesity: mechanisms and practical consequences in children and adults. Horm. Res. Pediatr. 73, 153-160
154. Wieczorek-Baranowska, A., Nowak, A., Michelak, E., Karolkiewicz, J., Pospieszna, B., Rutkowski, R., Laurentowska, M. and Pilaczynska-Szczesniak, L. (2011) Effect of aerobic exercise on insulin, insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in overweight and obese postmenopausal women. J. Sports Med. Phys. Fitness 51, 525-532
155. Ben Ounis, O., Elloumi, M., Zouhal, H., Makni, E., Denguezili, M., Amri, M., Lac, G. and Tabka, Z. (2010) Effect of individualised exercise training combined with diet restriction on inflammatory markers and IGF-1/IGFBP-3 in obese children. Ann. Nutr. Metab. 56, 260-266
156. Mitterberger, M. C., Mattesich, M., Klaver, E., Piza-Katzer, H. and Zwerschke, W. (2011) Reduced insulin-like growth factor-I serum levels in formerly obese women subjected to laparoscopic adjustable gastric banding or diet-induced long term caloric restriction. J. Gerontol., Ser. A 66, 1169-1177
157. Gama, R., Teale, J. D. and Marks, V. (1990) The effect of very low calorie diets on the GH-IGF-I axis in obese subjects. Clin. Chim. Acta 188, 31-38
158. Braun, S., Bitton-Worms, K. and LeRoith, D. (2011) The link between the metabolic syndrome and cancer. Int. J. Biol. Sci. 7, 1003-1015
159. Tong, P. C., Ho, C. S., Yeung, V. T., Ng, M. C., So, W. Y., Ozaki, R., Ko, G. T., Ma, R. C., Poon, E., Chan, N. N. et al. (2005) Association of testosterone, insulin-like growth-factor-I and C-reactive protein with metabolic syndrome in Chinese middle-aged men with a family history of type 2 diabetes. J. Clin. Endocrinol. Metab. 90, 6418-6423
160. Efstratiadis, G., Tsiaousis, G., Athyros, V. G., Karagianni, D., Pavlitou-Tsiontsi, A., Giannakou-Darda, A. and Manes, C. (2006) Total serum insulin-like growth factor-I and C-reactive protein in metabolic syndrome with or without diabetes. Angiology 57, 303-311
161. Heald, A. H., Anderson, S. G., Ivison, F., Laing, I., Gibson, J. N. and Cruickshank, K. (2003) C-reactive protein and the insulin-like growth factor (IGF)-system in relation to risk of cardiovascular disease in different ethnic groups. Atherosclerosis 170, 79-86
162. Andreassen, M., Raymond, I., Hildebrandt, P., Kistorp, C., Rathcke, C., Vestergaard, H., Faber, J. and Kristensen, L. O. (2010) Associations between plasma insulin-like growth factor-I and the markers of inflammation interleukin 6, C-reactive protein and YKL-40 in an elderly background population. Inflamm. Res. 59, 503-510
163. Colangelo, L. A., Chiu, B., Kopp, P., Liu, K. and Gapstur, S. M. (2009) Serum IGF-I and C-reactive protein in healthy black and white young men: the CARDIA male hormone study. Growth Horm. IGF Res. 19, 420-425
164. Nindl, B. C. and Pierce, J. R. (2010) Insulin-like growth factor-I as a biomarker of health, fitness, and training status. Med. Sci. Sports Exercise 42, 39-49
165. Nindl, B. C., Santtila, M., Vaara, J., Hakkinen, K. and Kyrolainen, H. (2011) Circulating IGF-I is associated with fitness and health outcomes in a population of 846 young men. Growth Horm. IGF Res. 21, 124-128
166. Frystyk, J., Skjaerbaek, C., Dinesen, B. and Orskov, H. (1994) Free insulin-like growth factors (IGF-I and IGF-II) in human serum. FEBS Lett. 348, 185-191
167. Stoving, R. K., Flyvbjerg, A., Frystyk, J., Fisker, S., Hangaard, J., Hansen-Nord, M. and Hagen, C. (1999) Low serum levels of free and total insulin-like growth factor I (IGF-I) in patients with anorexia nervosa are not associated with increased IGF-binding protein-3 proteolysis. J. Clin. Endocrinol. Metab. 84, 1346-1350
168. Saitoh, H., Kamoda, T., Nakahara, S. and Matsui, A. (1999) Insulin-like growth factor binding protein-1 (IGFBP-1) as a predictor of glucose stimulated hyperinsulinaemia in pre-pubertal obese children. Eur. J. Endocrinol. 140, 231-234
169. Heald, A. H., Kaushal, K., Siddals, W., Rudenski, A. S., Anderson, S. G. and Gibson, J. M. (2006) IGFBP-2 is a marker for the metabolic syndrome. Exp. Clin. Endocrinol. Diabetes 114, 371-376
170. Chen, J. W., Ledet, T., Orskov, H., Jessen, N., Lund, S., Whittaker, J., DeMeyts, P., Larsen, M. B., Christiansen, J. S. and Frystyk, J. (2003) A highly sensitive and specific assay for determination of IGF-I bioactivity in human serum. Am. J. Physiol. Endocrinol. Metab. 284, E1149-E1155
171. Brugts, M. P., Ranke, M. B., Hofland, L. J., van der Wansem, K., Weber, K., Frystyk, J., Lamberts, S. W. and Janssen, J. A. (2008) Normal values of circulating insulin-like growth factor-I bioactivity in the healthy population: comparison with five widely used IGF-I immunoassays. J. Clin. Endocrinol. Metab. 93, 2539-2545
172. Brugts, M. P., Tjiong, H. L., Rietveld, T., Wattimena, J. L., van den Berg, J. W., Fieren, M. W. and Janssen, J. A. (2010) Nephrol., Dial., Transplant. 25, 940-946
173. Brugts, M. P., van Duijn, C. M., Hofland, L. J., Witteman, J. C., Lamberts, S. W. and Janssen, J. A. (2010) IGF-I bioactivity in an elderly population: relation to insulin sensitivity, insulin levels and the metabolic syndrome. Diabetes 59, 505-508
174. Ellegard, L. H. and Bosaeus, I. G. (2008) Biochemical indices to evaluate nutritional support for malignant disease. Clin. Chim. Acta 390, 23-27
175. Mesotten, D. and van den Berghe, G. (2006) Changes within the GH/IGF-I/IGFBP axis in critical illness. Crit. Care Clin. 22, 17-28
176. Heinrich, P. C., Castell, J. V. and Andus, T. (1990) Interleukin-6 and the acute phase response. Biochem. J. 265, 621-636
177. Hawker, F. H., Stewart, P. M., Baxter, R. C., Borkman, M., Tan, K., Caterson, I. D. and McWilliam, D. B. (1987) Relationship of somatomedin-C/insulin-like growth factor-I levels to conventional nutritional indices in critically ill patients. Crit. Care Med. 15, 732-736
178. Kong, A. P., Choi, K. C., Wong, G. W., Ko, G. T., Ho, C. S., Chan, M. H., Ozaki, R., Ma, R. C., Lau, J. T., Chan, JC et al. (2011) Serum concentrations of insulin-like growth factor-I, insulin-like growth factor binding protein-3 and cardiovascular risk factors in adolescents. Ann. Clin. Biochem. 48, 263-269
179. Ankrah-Tetteh, T., Wijeratne, S. and Swaminathan, R. (2008) Intraindividual variation in serum thyroid hormones, parathyroid hormone and insulin-like growth factor-1. Ann. Clin. Biochem. 45, 167-169
180. Fraser, C. G. (1983) Desirable performance standards for clinical chemistry tests. Adv. Clin. Chem. 23, 299-339
181. Gelander, L., Blum, W. F., Larsson, L., Rosberg, S. and Albertsson-Wikland, K. (1999) Monthly measurements of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in healthy pre-pubertal children: characterisation and relationship with growth: the 1 year growth study. Pediatr. Res. 45, 377-383
182. Ricos, C., Alvarez, V., Cava, F., Garcia-Lario, J. V., Hernandez, A., Jimenez, C. V., Minchinela, J., Perich, C. and Simon, M. (1999) Current databases on biological variation: pros, cons and progress. Scand. J. Clin. Lab. Invest. 59, 491-500
183. Clemmons, D. R. (2011) Consensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assays. Clin. Chem. 57, 555-559